Home › NCT06744907

Safety and Efficacy of Subdermal Betadine During Posterior Spinal Fusion

Subdermal Betadine to Reduce Microbacterial Bioburden During Posterior Spinal Fusion

Who can join

Up to age 26 · All sexes

Inclusion Criteria

* Males and females
* Undergoing primary posterior spinal fusion of the thoracic and/or lumbar spine
* English Speaking

Exclusion Criteria

* Patients who have undergone prior spinal surgery
* Undergoing procedures other than primary posterior spinal fusion of the thoracic and/or lumbar spine (cervical fusion, anterior surgery, growth-friendly instrumentation)
* Any contraindication to povidone-iodine, including pregnancy, allergy, or prior treatment with radioiodine

About the study

Bacterial in the subdermal layer of the skin, such as in hair follicles and sweat glands, may contaminate surgical wounds. The goal of this study is to learn about povidone-iodine and its ability to prevent infections specifically in patients with scoliosis receiving a spinal fusion.

What is being tested

• 10% Povidone-Iodine Arm (biological)
• Saline Arm (procedure)

Sponsor: Akron Children's Hospital · Participants: 60 · Started: Jan 3, 2025

Contact the study team

• Alexandria Rundell, BS · Phone: 330-543-3193
• Lorena Floccari, MD · Phone: 330-543-3193

Official record on ClinicalTrials.gov — NCT06744907

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.